Michaël Chopin

Michaël Chopin

Auto-generated profile, based on publicly available information

Michaël Chopin

Department of Biochemistry, Monash Biomedicine Discovery Institute, Monash University, Clayton, Australia

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2013 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
LRLucille C Rankin
Lucille C Rankin
JGJoanna R Groom
Joanna R Groom
MCMichaël Chopin
Michaël Chopin
MHMarco Herold
Marco Herold
JWJennifer A Walker
Jennifer A Walker
GBGabrielle T. Belz
Gabrielle T. Belz

4 August 2014 in Journal of Experimental Medicine
Verified
Journal Article
Open access
CSCyril Seillet
Cyril Seillet
LRLucille C. Rankin
Lucille C. Rankin
JGJoanna R. Groom
Joanna R. Groom
LMLisa A. Mielke
Lisa A. Mielke
JTJulie Tellier
Julie Tellier
SCSebastian Carotta
Sebastian Carotta
Innate lymphoid cell (ILC) populations protect against infection and are essential for lymphoid tissue formation and tissue remodeling after damage. Nfil3 is implicated in the function of adaptive immune lineages and NK cell development, but it is not yet known if Nfil3 regulates other innate lymphoid lineages. Here, we identify that Nfil3 is essential for the development of Peyer’s patches and ILC2 and ILC3 subsets. Loss of Nfil3 selectively reduced Peyer’s patch formation and was accompanied by impaired recruitment and distribution of lymphocytes within the patches. ILC subsets exhibited high Nfil3 expression and genetic deletion of Nfil3 severely compromised the development of all subsets. Subsequently, Nfil3−/− mice were highly susceptible to disease when challenged with inflammatory or infectious agents. Thus, we demonstrate that Nfil3 is a key regulator of the development of ILC subsets essential for immune protection in the lung and gut.

14 August 2014 in Nature Communications
Verified
Journal Article
Closed access
PDF file
PSPriyanka Sathe
Priyanka Sathe
RDRebecca B. Delconte
Rebecca B. Delconte
Fernando Souza-Fonseca-GuimaraesFernando Souza-Fonseca-Guimaraes
Fernando Souza-Fonseca-Guimaraes
CSCyril Seillet
Cyril Seillet
MCMichael Chopin
Michael Chopin
Nicholas D HuntingtonNicholas D Huntington
Nicholas D Huntington

1 June 2020 in Immunity
Verified
Journal Article
Closed access
SNStephen Nutt
Stephen Nutt
MCMichaël Chopin
Michaël Chopin

6 October 2014 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
SCSebastian Carotta
Sebastian Carotta
SWSimon N. Willis
Simon N. Willis
JHJhagvaral Hasbold
Jhagvaral Hasbold
MIMichael Inouye
Michael Inouye
SPSwee Heng Milon Pang
Swee Heng Milon Pang
SNStephen Nutt
Stephen Nutt
Activated B cells undergo immunoglobulin class-switch recombination (CSR) and differentiate into antibody-secreting plasma cells. The distinct transcriptomes of B cells and plasma cells are maintained by the antagonistic influences of two groups of transcription factors: those that maintain the B cell program, including BCL6 and PAX5, and plasma cell–promoting factors, such as IRF4 and BLIMP-1. We show that the complex of IRF8 and PU.1 controls the propensity of B cells to undergo CSR and plasma cell differentiation by concurrently promoting the expression of BCL6 and PAX5 and repressing AID and BLIMP-1. As the PU.1–IRF8 complex functions in a reciprocal manner to IRF4, we propose that concentration-dependent competition between these factors controls B cell terminal differentiation.

17 October 2013 in Blood
Verified
Journal Article
Open access
PDF file
YZYuxia Zhang
Yuxia Zhang
JMJovana Maksimovic
Jovana Maksimovic
GNGaetano Naselli
Gaetano Naselli
JQJunyan Qian
Junyan Qian
MCMichael Chopin
Michael Chopin
LHLeonard C. Harrison
Leonard C. Harrison
Key Points: Human naive CD4+ T cells and resting nTreg are differentially methylated at 127 regions in their genomic DNA. Forkhead-binding motifs are present in promoter-associated differentially methylated regions, inferring broader epigenetic control of Treg.